The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

Belief is your safe passage—the door through which all healing resides. Why? Because your perception is your reality. Believing in the science of TMS ( tension myositis syndrome) sends a message of ...

Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Austin is alive today because of the expertise of his world-class neurosurgeon and Radiothon listeners funding vital ...

An international team of researchers, led by the University of Glasgow, hopes to find new ways to target opioid addiction ...

If you’re exploring ways to spice up your wellness routine, chances are turmeric supplements have caught your attention.

Cutting Edge Health, led by Orlando A. Landrum, MD, MBA—recognized for advanced interventional neuroscience ...

Neurolief, a leader in brain stimulation for mental health and neurological disorders, is pleased to announce the appointment of Owen Scott Muir, M.D.

Tinnitus affects millions of people worldwide, often leading to frustration, confusion and a sense of isolation. This ...

Neurolief, a leader in brain stimulation for mental health and neurological disorders, is pleased to announce the appointment of Owen Scott Muir, M.D., DFAACAP, as its fractional Chief Medical Officer ...